TrianglePUBLICATIONS · 21990409
Sensitive detection of BCR-ABL1 mutations in patients with chronic myeloid leukemia after imatinib resistance is predictive of outcome during subsequent therapy.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2011 Nov 10
- First author
- Parker WT
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Parker WT
- type
- Author
- name
- Lawrence RM
- type
- Author
- name
- Ho M
- type
- Author
- name
- Irwin DL
- type
- Author
- name
- Scott HS
- type
- Author
- name
- Hughes TP
- type
- Author
- name
- Branford S
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Parker WT
- type
- Author
- name
- Lawrence RM
- type
- Author
- name
- Ho M
- type
- Author
- name
- Irwin DL
- type
- Author
- name
- Scott HS
- type
- Author
- name
- Hughes TP
- type
- Author
- name
- Branford S
- type
- Author
- bibliography ids
- nci-bib-f11238d670333280a545607f
- book metadata
- content sha256
- 5124314c31528f5350af0e452602e363625e1fb36f45ee1ab9efb95e4c17a976
- document type
- citation
- dois
- 10.1200/JCO.2011.35.0934
- electronic publication date
- display
- 2011 Oct 11
- precision
- day
- year
- 2011
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:21990409
- immutable id
- pubmed:21990409@5124314c31528f5350af0e452602e363625e1fb36f45ee1ab9efb95e4c17a976
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 32
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 4250-9
- volume
- 29
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 21990409
- provenance
- batch id
- 2529ef2eca926738ab13
- provider
- NCBI PubMed ESummary
- record sha256
- 7a3537b1a7d1c36d666c78b2d71ffec5cc09df9907704238fa3b61fc34aaf8d4
- response sha256
- 9204e3dd8d67df5a6773613a8059d8d42d9842ee24eecc9b0f39a62f636c99b6
- retrieved at
- 2026-09-09T23:46:42.856296+00:00
- publication date
- display
- 2011 Nov 10
- precision
- day
- year
- 2011
- publication types
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Sensitive detection of BCR-ABL1 mutations in patients with chronic myeloid leukemia after imatinib resistance is predictive of outcome during subsequent therapy.
Preserved source evidence · Not medical advice